Equity Overview
Price & Market Data
Price: $2.40
Daily Change: -$0.30 / 12.50%
Daily Range: $2.35 - $2.69
Market Cap: $98,603,280
Daily Volume: 216,988
Performance Metrics
1 Week: -10.11%
1 Month: 37.93%
3 Months: 124.3%
6 Months: 52.87%
1 Year: 9.09%
YTD: 42.86%
Company Details
Employees: 3
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. Its lead product candidate is the selonabant, a small molecule antagonist of cannabinoid binding receptor type-1, which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. The company was incorporated in 2020 and is based in Lakeway, Texas.